Deferred registration - Quotient Sciences code: QSC303694
This study is an early-stage clinical trial (Phase 1) run by Quotient Sciences in the UK. It is looking for healthy male volunteers aged between 18 and 65. The main goal of this type of study is to test the safety of a new medicine, watch for any side effects, and see how the human body absorbs and clears it. Because this study is in its very early stages, the full details of the medicine being tested are temporarily withheld from the public register under an official agreement called a deferred registration. This is common practice to protect new scientific research while initial safety checks are carried out. Men who join will be monitored closely by a dedicated medical team at every step to ensure they stay safe and well.
At a glance
What is this study about?
Before any new medicine can be used to treat patients in NHS hospitals or clinics, it must go through careful safety testing. Phase 1 trials are the first step where a new treatment is given to human volunteers. This study, managed by a research company called Quotient Sciences, aims to check that a new medicine is safe, see what effects it produces, and learn how it moves through the bloodstream.
At this moment, the specific name and purpose of the medicine are not published on the public database. This is known as a 'deferred registration.' Drug developers sometimes delay publishing commercial and scientific details until the early testing is complete. Even though the details are not yet public, the trial must still follow strict UK safety regulations and receive approval from an independent research ethics committee before any volunteer can join.
Studies like this are vital for medical progress. By checking medicines in healthy volunteers first, researchers can find out the right dose to use and make sure there are no unexpected harmful reactions. The knowledge gained helps scientists decide if the treatment is safe enough to test in people who actually have the condition the medicine is designed to treat.
Key takeaways
- Phase 1 safety trial running in the UK for healthy men aged 18 to 65.
- Aims to check the safety and body processing of a new medicine.
- Full scientific details are temporarily withheld under an approved deferral.
- Volunteers are closely looked after in a specialist medical clinic.
- Participation is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
This trial is specifically for healthy male volunteers between the ages of 18 and 65. Because this is a Phase 1 safety trial, researchers need people who do not have ongoing health conditions so they can clearly see how the medicine acts on a healthy body without other illnesses getting in the way.
While the full medical checklist has not been published yet, healthy volunteer trials usually require you to have normal blood pressure, a healthy weight, and normal blood and urine test results. You will typically be excluded if you smoke heavily, drink large amounts of alcohol, take regular prescription medicines, or have a history of serious heart, liver, or kidney problems.
If you contact the research centre, their team will carry out a full health check to see if you meet all the safety rules. You will only be invited to take part if the doctors are confident that it is safe for you to do so.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a man aged between 18 and 65.
- I consider myself to be in good general health.
- I do not take regular prescription medications.
- I have no history of major heart, kidney, or liver disease.
- I am able to stay overnight at a UK clinic and attend follow-up visits.
What does participation involve?
Taking part in a Phase 1 study usually requires an initial screening appointment where the team checks your medical history and runs blood, urine, and heart tests (such as an ECG). If you are accepted, you will likely need to stay overnight at a specialist clinical research unit for a few days so the staff can monitor you round the clock. During your stay, you will receive the study medicine—usually as a tablet, liquid, or injection—and regular blood samples will be taken to measure the drug levels in your body. After leaving the clinic, you will have one or more follow-up visits to check your health before the trial finishes.
Potential risks and benefits
Locations (1)
- Quotient Sciences LimitedUnverifiedNottingham, England
Common questions
Why is this trial only open to men?
Early trials often focus on one sex to keep the group as uniform as possible and to avoid any potential risks to pregnancy or unborn children before safety is proven.
What does 'deferred registration' mean?
It means the scientists have official permission to delay sharing full details of the medicine publicly to protect their new scientific ideas while initial tests take place.
Will I be paid for taking part?
Most Phase 1 trials with healthy volunteers provide financial compensation to cover your time, travel, and the inconvenience of clinic stays.
Is the study safe even if details are deferred?
Yes. The study still has to be thoroughly reviewed and approved by UK medical regulators and an independent ethics committee before it can begin.
Can I leave the study if I change my mind?
Yes, you can leave at any point. Your safety is the priority, and you are never forced to stay or take medicine you are uncomfortable with.
How to find out more
Clinical Operations
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.